CDT Equity CDT
NASDAQ CDT
$1.36 -0.09 (-6.21%)
At close: Sep 30, 2026 · 4:00 PM EDT

CDT Equity (CDT) EBITDA (2024 - 2026)

Updated

CDT Equity's EBITDA was -$2.69 million in Q2 2026, compared with -$4.58 million a year earlier.

Analysis

CDT Equity (CDT) EBITDA (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, CDT Equity's EBITDA was -$33.59 million through Jun 30, 2026; for FY2025, it came in at -$35.34 million.

  • In earlier years, EBITDA was -$13.74 million in FY2024.
  • Per Business Quant data, CDT's EBITDA in the three quarters before Q2 2026 was -$3.38 million (Q1 2026), -$20.88 million (Q4 2025) and -$6.64 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 9.10 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 8.33 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 999.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 5.09 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 4.63 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -9.70 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 5.89 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 1.30 Bn
10 CDT Equity 36,602.35 36,602.35 - -2.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.69 Mn
Mar 31, 2026 -3.38 Mn
Dec 31, 2025 -20.88 Mn
Sep 30, 2025 -6.64 Mn
Jun 30, 2025 -4.58 Mn
Mar 31, 2025 -3.24 Mn
Dec 31, 2024 -3.14 Mn
API Access

CDT Equity EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=CDT&period=max&api_key=YOUR_API_KEY